A medical marijuana advocate in Saskatoon is raising a stink about one company's plan to ban all types of smoking in its rental apartments starting this fall.

The policy, confirmed Thursday, will apply to smoking marijuana and cigarettes, plus vaping, inside more than 11,000 Mainstreet Equity Corp. apartments and attached patios in Saskatchewan, Alberta and B.C.

Smokers will have to take it outside to designated areas starting around Sept. 1, a month before cannabis is legalized in Canada, the company told CBC News.

"I think it's somewhat ridiculous," said Mike Francis, a spokesperson for Best Buds, a group that links people with doctors that prescribe medical marijuana.

The Jamaica Medical Cannabis Corporation (JMMC) is investing US$2 million (J$264,000,000) into research on local ganja strains in order to ascertain with scientific accuracy their medicinal potential, over the next 10 years.

Professor Errol Morrison, director general of the National Commission on Science and Technology, spoke to the enormity of the project titled ‘Identification, Isolation and Conservation of Local Strains of Cannabis for Medicinal Use’ during Monday’s signing ceremony.

“What you are about to witness is the dedication of our scientific community to eventually [map] the scientific identification of our strain. Not a look, touch, smell, feel (but) DNA science to underpin what it is that we have been making claims for centuries," he said.

It could still be several years before Health Canada lets companies make health claims for marijuana products but industry is getting ready.

Three months after announcing a deal with cannabis grower Tilray Inc., generic drug major Sandoz Canada Inc. has signed off on the use of its name for marijuana products.

On Tuesday, the company, a subsidiary of Novartis International AG, one of the largest pharmaceutical companies in the world, announced that eight of Tilray’s non-combustible products, already sold under Canada’s mail-order medical marijuana system, would start carrying Sandoz branding.     

Canadian shareholders will receive 1 share in new company for every 20 Aurora shares they own.

Canada's second largest cannabis company plans to place its U.S. assets into a new separate company that will focus on investing in the cannabis and real estate sector there.

TSX-listed Aurora Cannabis said Wednesday it plans to distribute units of its subsidiary Australis Capital Inc. to shareholders in the near future.

More than half (52 per cent) of Canadian employers said they’re concerned or very concerned about the implications of legalized marijuana on the workplace, according to a report by the Conference Board of Canada.

A third (33 per cent) of respondents said they’re slightly concerned and 15 per cent said they aren’t concerned at all. Among those concerned, 57 per cent cited workplace safety, followed by impairment or intoxication at work (39 per cent); increased use of the drug in and out of the workplace (21 per cent); testing for impairment (20 per cent); managing needs related to accommodation and disclosure (15 per cent); and the cost, including covering medical marijuana and other financial affects on the organization (15 per cent).

Sandoz Canada today announced that it has finalized its collaboration agreement with Tilray, a Health Canada licensed producer of medical cannabis, allowing Sandoz Canada to become the first Canadian pharmaceutical company to enter the medical cannabis field. The alliance will support the rising interest in medical cannabis1 by providing patients with medical treatment options of stringent manufacturing standards that are adapted to their medical conditions, advocating for broader access to products, and increasing product innovation, research and education.

Terra Life Sciences shows the power of value-added processing in its cannabis cultivation facility and pharmaceutical plant.

Terra Life Sciences would look like any other manufacturing plant if not for the security guard parked out front.

He’s the gatekeeper here. You’ll find another one just like him at the other gate, checking in visitors, scrutinizing IDs, buzzing through the people who pass muster.

But these guards are just your first glimpse of the Fort Knox-style security system at the Olds-based pharmaceutical company. As you make your way through the greenhouse and manufacturing plant, you’ll see plenty more — hundreds of cameras lining the walls, passcodes on nearly every entryway, alarms that wail when you leave a door open a little too long.

When cannabis stores open across Canada later this year, it will look very different than in Colorado.

On a blustery New Year’s Day four years ago, throngs of people in toques and jackets lined up in parking lots and on sidewalks across Colorado waiting for the end of prohibition. At 8 a.m., more than two dozen marijuana dispensaries opened their doors for recreational sales. By the end of the first week of sales, locals and tourists alike had reportedly spent US$5 million on weed.

As cannabis legalization spreads across the North American continent, industry insiders and pot stock investors alike look to diversify their portfolios in the global marijuana trade.

With Canada on track to become the first G7 nation to legalize both recreational and medical cannabis nationally, overcrowding in the market is becoming an issue for stakeholders on all sides. It’s the reason why cannabis companies are starting to look for more opportunities internationally. These are the top four marijuana stocks with international expansion plans:

The licensed cannabis producer Tilray has become one of the few cannabis business with a female majority on their board of directors. Today, they welcomed Rebekah Dopp, Maryscott "Scotty" Greenwood and Christine St.Clare to their Board, writes Calvin Hughes.